Loading...
•
Jun 30, 2022
AdaptHealth Q2 2022 Earnings Report
Announced financial results for the second quarter ended June 30, 2022.
Key Takeaways
AdaptHealth reported its Q2 2022 results, highlighting resilience in HME and Sleep product lines with CPAP patient setups near record levels and a 16% increase in rental census from February levels. The diabetes product line also posted double-digit growth. The company maintains its fiscal year 2022 guidance.
Cash flow from operations was $103.5 million, compared to $129.2 million in the second quarter of 2021.
HME and Sleep product lines showed continued resilience.
CPAP patient set ups remain at or near record levels resulting in rental census up 16% from February levels.
Diabetes product line continues to post double-digit growth.
Forward Guidance
The Company is maintaining its previously issued financial guidance for fiscal year 2022. Guidance for fiscal year 2022 does not include any contribution from acquisitions that have not yet closed, or continuing Public Health Emergency benefits beyond the currently scheduled expiration date.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...